Search results for: 'market and acquisition deaco of 221b'
- Did you mean
- market and acquisition deal of 221b
- Related search terms
- acquisition texas and agreements in pharma
- acquisition teva and agreements in pharma
- acquisitions terms and agreements in pharma
- acquisitions test and agreements in pharma
- 221b data alliances review
-
Asset Purchase Deals in Pharmaceuticals and Biotechnology 2019 to 2025September 2025$3,995.00Asset Purchase Deals in Pharmaceuticals and Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2019 to 2025
Learn More -
Clinical Stage Partnering Terms and Agreements in Pharmaceuticals and Biotechnology 2019-2025August 2025$4,995.00The Clinical Stage Partnering Terms and Agreements in Pharma and Biotech report offers in-depth insights and exclusive access to clinical-stage partnering agreements signed by the world’s leading biopharma companies, providing a detailed analysis of deal structures, financial terms and strategic collaborations.
Learn More -
Gastrointestinal Collaboration and Licensing Deals 2016-2025October 2025$3,995.00Gastrointestinal Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals | Comprehensive deal directory 2016 to 2025
Learn More -
Musculoskeletal Collaboration and Licensing Deals 2016-2025October 2025$3,995.00Musculoskeletal Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals | Comprehensive deal directory 2016 to 2025
Learn More -
Dermatology Collaboration and Licensing Deals 2016-2025October 2025$3,995.00Dermatology Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Monoclonal Antibody Collaboration and Licensing Deals 2019-2025May 2025$3,995.00Monoclonal Antibody Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Ophthalmics Collaboration and Licensing Deals 2019-2025October 2025$3,995.00Ophthalmics Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals | Comprehensive deal directory 2019 to 2025
Learn More -
Hospital Care Collaboration and Licensing Deals 2016-2025October 2025$3,995.00Hospital Care Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Regenerative Medicine Collaboration and Licensing Deals 2019-2025May 2025$3,995.00Regenerative Medicine Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2019 to 2025
Learn More -
Antibiotic Collaboration and Licensing Deals 2016-2025July 2025$3,995.00Antibiotic Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More
